These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 9178675)
1. Genetic markers may predict disease behavior in patients with ulcerative colitis. Roussomoustakaki M; Satsangi J; Welsh K; Louis E; Fanning G; Targan S; Landers C; Jewell DP Gastroenterology; 1997 Jun; 112(6):1845-53. PubMed ID: 9178675 [TBL] [Abstract][Full Text] [Related]
2. Genetic heterogeneity within ulcerative colitis determined by an interleukin-1 receptor antagonist gene polymorphism and antineutrophil cytoplasmic antibodies. Papo M; Quer JC; Gutierrez C; Broch M; Casellas F; Pastor RM; Olona M; Richart C Eur J Gastroenterol Hepatol; 1999 Apr; 11(4):413-20. PubMed ID: 10321759 [TBL] [Abstract][Full Text] [Related]
3. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis. Bioque G; Bouma G; Crusius JB; Koutroubakis I; Kostense PJ; Meuwissen SG; Peña AS Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):105-10. PubMed ID: 8723412 [TBL] [Abstract][Full Text] [Related]
4. Lack of association between HLA-DRB1 alleles of the major histocompatibility complex and p-ANCA status or clinical characteristics in patients with ulcerative colitis. Folwaczny C; Zahn R; Brünnler G; Albert E; Koenig A; Noehl N; Loeschke K; Fricke H Z Gastroenterol; 1999 Feb; 37(2):133-40. PubMed ID: 10190246 [TBL] [Abstract][Full Text] [Related]
5. Association of the HLA-DRB1*0701 allele with perinuclear anti-neutrophil cytoplasmatic antibodies in Mexican patients with severe ulcerative colitis. Yamamoto-Furusho JK; Uscanga-Domínguez L; Lopez-Martinez A; Granados J World J Gastroenterol; 2006 Mar; 12(10):1617-20. PubMed ID: 16570357 [TBL] [Abstract][Full Text] [Related]
6. Association of HLA-DRB1 alleles and anti-neutrophil cytoplasmic antibodies in Han and Uyghur patients with ulcerative colitis in China. Gao F; Aheman A; Lu JJ; Abuduhadeer M; Li YX; Kuerbanjiang A J Dig Dis; 2014 Jun; 15(6):299-305. PubMed ID: 24597629 [TBL] [Abstract][Full Text] [Related]
8. Genetic markers in clinically well defined patients with ulcerative colitis (UC). Bouma G; Crusius JB; García-González MA; Meijer BU; Hellemans HP; Hakvoort RJ; Schreuder GM; Kostense PJ; Meuwissen SG; Peña AS Clin Exp Immunol; 1999 Feb; 115(2):294-300. PubMed ID: 9933456 [TBL] [Abstract][Full Text] [Related]
9. [Interleukin (IL)-1beta, IL-1 receptor antagonist and IL-4 gene polymorphisms in ulcerative colitis in the Chinese]. Peng Z; Hu P; Cui Y; Li C Zhonghua Nei Ke Za Zhi; 2002 Apr; 41(4):248-51. PubMed ID: 12133437 [TBL] [Abstract][Full Text] [Related]
10. Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup. Duerr RH; Neigut DA Gastroenterology; 1995 Feb; 108(2):423-7. PubMed ID: 7835583 [TBL] [Abstract][Full Text] [Related]
11. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers. Yang H; Rotter JI; Toyoda H; Landers C; Tyran D; McElree CK; Targan SR J Clin Invest; 1993 Aug; 92(2):1080-4. PubMed ID: 8349790 [TBL] [Abstract][Full Text] [Related]
12. Association of IL-10 and TNFalpha genotypes with ANCA appearance in ulcerative colitis. Castro-Santos P; Suarez A; Mozo L; Gutierrez C Clin Immunol; 2007 Jan; 122(1):108-14. PubMed ID: 17070109 [TBL] [Abstract][Full Text] [Related]
13. Are HLA-DR or TAP genes genetic markers of severity in ulcerative colitis? Heresbach D; Alizadeh M; Reumaux D; Colombel JF; Delamaire M; Danze PM; Gosselin M; Genetet B; Bretagne JF; Semana G J Autoimmun; 1996 Dec; 9(6):777-84. PubMed ID: 9115580 [TBL] [Abstract][Full Text] [Related]
14. Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis. Hov JR; Boberg KM; Taraldsrud E; Vesterhus M; Boyadzhieva M; Solberg IC; Schrumpf E; Vatn MH; Lie BA; Molberg Ø; Karlsen TH Liver Int; 2017 Mar; 37(3):458-465. PubMed ID: 27558072 [TBL] [Abstract][Full Text] [Related]
15. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Satsangi J; Welsh KI; Bunce M; Julier C; Farrant JM; Bell JI; Jewell DP Lancet; 1996 May; 347(9010):1212-7. PubMed ID: 8622450 [TBL] [Abstract][Full Text] [Related]
16. The presence of anti-neutrophil antibodies reflects clinical and genetic heterogeneity within inflammatory bowel disease. Satsangi J; Landers CJ; Welsh KI; Koss K; Targan S; Jewell DP Inflamm Bowel Dis; 1998 Feb; 4(1):18-26. PubMed ID: 9552224 [TBL] [Abstract][Full Text] [Related]
17. Genetic markers linked to rheumatoid arthritis are also strongly associated with articular manifestations in ulcerative colitis patients. Núñez C; Alecsandru DM; Mendoza JL; Urcelay E; Díaz-Rubio M; de la Concha EG; Martinez A Hum Immunol; 2006; 67(4-5):324-30. PubMed ID: 16720213 [TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of unfixed and fixed human neutrophils for determination of antineutrophil cytoplasmic antibodies by indirect immunofluorescence. Yang P J Clin Pathol; 1997 Aug; 50(8):677-80. PubMed ID: 9301553 [TBL] [Abstract][Full Text] [Related]
19. HLA antigens and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease. García Herola A; Nos P; Hinijosa J; Hoyos M; Molés JR; Carmona E; Puig N; Sánchez-Cuenca JM; Ponce J; Berenguer J Rev Esp Enferm Dig; 2003 Nov; 95(11):760-4, 755-9. PubMed ID: 14640873 [TBL] [Abstract][Full Text] [Related]
20. Polymorphism of HLA-DRB1 gene shows no strong association with ulcerative colitis in Chinese patients. Lü M; Xia B Int J Immunogenet; 2006 Feb; 33(1):37-40. PubMed ID: 16426241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]